Erika Mackie, PharmD (@mackieerika) 's Twitter Profile
Erika Mackie, PharmD

@mackieerika

Critical Care Clinical Specialist @OhioHealth - PGY2 @saintjosephs + @CooperHealthNJ - PGY1 @WVUHPharmRes - PharmD ‘22 @TU_SP - BS Chemistry ‘18 @Canisius_Univ

ID: 1422922796246646793

linkhttps://www.linkedin.com/in/erika-mackie-256952135/ calendar_today04-08-2021 14:10:21

124 Tweet

125 Followers

148 Following

Rachel_EMPharmD (@rachel_empharmd) 's Twitter Profile Photo

Hi all! Our PGY2 EM has elected not to participate in the ASHP showcase this year. We will be hosting our own virtual showcase at no cost to you! Please stay tuned for details!

Tyler Ackley, PharmD (@ackley_pharmd) 's Twitter Profile Photo

Hunter O. Rondeau Not sure if here is the best place to tag on but, Hartford Hospital is going into Phase II for our ID PGY-2 program. If anyone is interested in hearing more about the program, feel free to send me a DM as a previous-resident turned preceptor!!

Heather Schucker, PharmD, BCEMP (@heathers_pharmd) 's Twitter Profile Photo

Our EM PGY2 at Lakeland Regional didn’t match in Phase 1 BUT we haven’t given up on finding our perfect fit!!! If you or someone you know is still looking for a PGY2 in EM check us out!!! 🚑💊

Our EM PGY2 at Lakeland Regional didn’t match in Phase 1 BUT we haven’t given up on finding our perfect fit!!! If you or someone you know is still looking for a PGY2 in EM check us out!!! 🚑💊
Pharmacy To Dose: The Critical Care Podcast (@pharmacytodose) 's Twitter Profile Photo

🚨NEW POD ALERT 🚨 Thrombolytic Dosing in PE: Versus Series Ft. Lauren Igneri Lauren Igneri Debating whether full or reduced dose thrombolysis is preferred in: -High-risk PE 🫁 -Intermediate-risk PE 🩸 -Cardiac arrest 🫀 And a bonus round trying to decide our preferred

🚨NEW POD ALERT 🚨
Thrombolytic Dosing in PE: Versus Series
Ft. Lauren Igneri <a href="/LIgneri_PharmD/">Lauren Igneri</a> 

Debating whether full or reduced dose thrombolysis is preferred in:
-High-risk PE 🫁
-Intermediate-risk PE 🩸
-Cardiac arrest 🫀

And a bonus round trying to decide our preferred
ACCP (@accp) 's Twitter Profile Photo

Congratulations to ACCP member Jay L. Martello and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: ow.ly/6J5i50ROV7i   #MakingAnImpact #TwitteRx #ACCP JACCP

Congratulations to ACCP member Jay L. Martello and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: ow.ly/6J5i50ROV7i
 
#MakingAnImpact #TwitteRx #ACCP <a href="/JACCPJournal/">JACCP</a>
Pharmacy To Dose: The Critical Care Podcast (@pharmacytodose) 's Twitter Profile Photo

🚨NEW POD ALERT 🚨 Trial of the Week: ROSE 🌹 Ft. Christina Rose Christina Rose Proposed mechanism for NMBA in ARDS 🫁 ACURASYS v. ROSE ⚔️ Adjunctive therapies received 💉 Current guideline recommendations 📜 Using alternate NMBA 🤔 Favorite concerts 👅 & much more! 🍎

🚨NEW POD ALERT 🚨
Trial of the Week: ROSE 🌹
Ft. Christina Rose <a href="/CRosePharmD/">Christina Rose</a>

Proposed mechanism for NMBA in ARDS 🫁
ACURASYS v. ROSE ⚔️
Adjunctive therapies received 💉
Current guideline recommendations 📜
Using alternate NMBA 🤔
Favorite concerts 👅
&amp; much more!

🍎
Open Forum Infectious Diseases (@ofidjournal) 's Twitter Profile Photo

Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales ✅ Just Accepted 🔗 bit.ly/3RTAVaD

Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales

✅ Just Accepted
🔗 bit.ly/3RTAVaD
Megan Rech, PharmD, MS (@meganarech) 's Twitter Profile Photo

🚨 ACEP Members ED Accreditation Criteria are out and thanks to SAEM & SAEM AEMP a pharmacist is now required for all Level 1 & Level 2 sites - THIS is the work we're doing to advance EM pharmacy practice 👐acep.org/siteassets/sit…

🚨 <a href="/ACEPNation/">ACEP Members</a> ED Accreditation Criteria are out and thanks to <a href="/SAEMonline/">SAEM</a> &amp; <a href="/SAEM_AEMP/">SAEM AEMP</a> a pharmacist is now required for all Level 1 &amp; Level 2 sites - THIS is the work we're doing to advance EM pharmacy practice 👐acep.org/siteassets/sit…
Alyssa Sykuta Meester, PharmD, BCCCP (@ameester_pharmd) 's Twitter Profile Photo

Well if this wasn’t a labor of love. Really proud of all those involved in this program for the after-hours effort that went into ensuring high-quality patient care for our MCS and PAH patients🫀 journals.sagepub.com/doi/10.1177/08…

Erika Mackie, PharmD (@mackieerika) 's Twitter Profile Photo

And who will be dosing the vanc? Assessing if an allergy is even real? Dosing based on the renal function you won’t have? Assessing previous culture data to help guide empiric therapy? The PharmDs you didn’t include in this guideline update?